Abiopharma

Ainos to Showcase AI Nose at SEMICON Taiwan 2025

New Form 8-K - FOXO TECHNOLOGIES INC. Filed: 2025-09-08 AccNo: 0001641172-25-026820 Size: 202 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - CASSAVA SCIENCES INC Filed: 2025-09-08 AccNo: 0001437749-25-028530 Size: 6 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

GE HealthCare Enters an Agreement to Distribute Flyrcado Through CDL Nuclear Technologies Group, a Leading Provider of Cardiac PET Imaging Equipment and Services in the U.S.

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

- Femasys Secures Regulatory Approval for FemBloc®Permanent Birth Control in New Zealand

New Form SCHEDULE 13G - electroCore, Inc. Filed: 2025-09-08 AccNo: 0002058477-25-000002 Size: 9 KB

New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM

New Form 8-K - Ainos, Inc. Filed: 2025-09-08 AccNo: 0001493152-25-012781 Size: 293 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

MediciNova Provides Shareholder Update on Key Developments

Summit Plc - Current report filing

New Form 8-K - ATOSSA THERAPEUTICS, INC. Filed: 2025-09-08 AccNo: 0000950170-25-113371 Size: 1 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - DENTSPLY SIRONA Inc. Filed: 2025-09-08 AccNo: 0000818479-25-000167 Size: 788 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Evolus, Inc. Filed: 2025-09-08 AccNo: 0001570562-25-000110 Size: 201 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits